Gold X2 Mining Inc. (TSXV: AUXX) (OTCQB: GSHRF) (FSE: DF8) (“Gold X2” or the “Company”) is pleased to announce a significant update ...
Discover Telos Corporation's Q3 2025 earnings: record revenue growth, Xacta.ai launch, and raised outlook for 2026.
Minute Audio Program Enters Brainwave Entrainment Sector Amid Surging Consumer Interest in Non-Invasive Focus Enhancement Solutions ...
Revenue -- Reported at $3.7 million for the three months ended September 30, 2025, up from $2.3 million in the same period in 2024; the increase was due to a $1.5 million rise in license revenues, ...
Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression ...
Bletchley Park was more than a place — it was a method. During World War II, the United Kingdom combined science, engineering ...
ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...
Atacicept met the primary endpoint of reduction in proteinuria (UPCR) at week 36; participants receiving atacicept achieved a 46% reduction from baseline and 42% reduction compared to placebo at week ...
The LRSD board has to start paying attention to spending. If you look at projected student enrollment declines, we cannot ...
UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...
At the end of the IMF program, by around 2028, Sri Lanka is projected to spend over 40% of Government revenue on debt repayments, one of the highest ratios among peer-group countries. With at least ...
American Critical Minerals has voluntarily filed a National Instrument 43-101 Technical Report supporting the exploration targets for Potash, Lithium and Bromine. 2.1 billion cubic meters (brine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results